Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

The impact of sex on clinical profiles of patients with behavioral variant frontotemporal dementia

Summarise with AI (MRCPsych/FRANZCP)

Alzheimers Dement. 2025 Dec;21(12):e70996. doi: 10.1002/alz.70996.

ABSTRACT

INTRODUCTION: Sex differences in behavioral variant frontotemporal dementia (bvFTD) remain understudied, especially when controlling for sex differences already existing in the general population.

METHODS: Clinical features were analyzed in 620 bvFTD participants. Sex-diagnosis interactions were examined in 1029 bvFTD and 1029 healthy control (HC) participants for neuropsychiatric symptoms, and in 1109 bvFTD and 1109 HC participants for cognitive, behavioral, and language measures.

RESULTS: Males with bvFTD showed greater-than-expected loss of empathy and nighttime behavioral symptoms relative to females, based on sex-by-diagnosis interactions. They also exhibited higher-than-expected punishment sensitivity. In contrast, females with bvFTD showed greater-than-expected impairments in semantic fluency and picture naming relative to HC females.

DISCUSSION: Findings reveal that males with bvFTD present with more prominent behavioral disturbances, while females with bvFTD experience greater language impairments. This work is an important step toward integrating social determinants of health, such as sex, into the diagnostic and care paradigms for bvFTD.

HIGHLIGHTS: Males with behavioral variant frontotemporal dementia (bvFTD) show more empathy loss and nighttime behavioral symptoms Females with bvFTD have greater deficits in naming and semantic fluency Findings support including sex in diagnostic and care models for bvFTD.

PMID:41457063 | DOI:10.1002/alz.70996

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD